Pamukkale University - Faculty of Medicine, Departamento de Cardiologia, Denizli - Turquia.
Arq Bras Cardiol. 2022 Jul;119(1):69-75. doi: 10.36660/abc.20210414.
Inflammation plays a key role in the initiation and progression of coronary artery disease (CAD). The systemic immune-inflammation index (SII) is a novel inflammatory parameter that has been shown to be associated with CAD.
This study aimed to investigate the relationship between SII and coronary collateral circulation (CCC) in patients with stable CAD and chronic total occlusion (CTO).
The patients were divided into two groups, with poor CCC and good CCC, according to the Rentrop Classification. Ninety-four patients had poor CCC, and 81 patients had good CCC. Inflammation parameters were calculated from the laboratory results. The statistical significance level applied was 0.05.
High SII level (OR: 1.003, 95% CI: 1.001-1.004, p<0,001), absence of CTO in RCA (OR: 0.204, 95% CI: 0.096-0.436, p<0,001) and low Gensini score (OR: 0.980, 95% CI: 0.962-0.998, p=0,028) were significantly associated with poor CCC. The cutoff value of SII was 679.96 for the highest predictive power of poor CCC, with a sensitivity of 74.5% and specificity of 43.2%. Mortality rates were similar between the two groups during a mean follow-up of 21.5±10.8 months (p=0.107).
High SII level, the absence of CTO in the right coronary artery, and low Gensini score were significantly related to poor CCC. The rapid and cost-effective use of new inflammatory markers in clinical practice guides the prognosis of CAD.
炎症在冠状动脉疾病(CAD)的发生和发展中起着关键作用。系统性免疫炎症指数(SII)是一种新的炎症参数,已被证明与 CAD 相关。
本研究旨在探讨稳定型 CAD 伴慢性完全闭塞(CTO)患者 SII 与冠状动脉侧支循环(CCC)之间的关系。
根据Rentrop 分级,将患者分为 CCC 差组和 CCC 好组。94 例患者 CCC 差,81 例患者 CCC 好。从实验室结果计算炎症参数。应用的统计显著性水平为 0.05。
高 SII 水平(OR:1.003,95%CI:1.001-1.004,p<0.001)、RCA 无 CTO(OR:0.204,95%CI:0.096-0.436,p<0.001)和低 Gensini 评分(OR:0.980,95%CI:0.962-0.998,p=0.028)与 CCC 差显著相关。SII 的截断值为 679.96,对 CCC 差的预测能力最高,灵敏度为 74.5%,特异性为 43.2%。两组在平均 21.5±10.8 个月的随访期间死亡率相似(p=0.107)。
高 SII 水平、右冠状动脉无 CTO 和低 Gensini 评分与 CCC 差显著相关。在临床实践中快速、经济地使用新的炎症标志物有助于指导 CAD 的预后。